You are currently viewing Psychedelic Drug Development Pipeline Updates (Q1’25)

Psychedelic Drug Development Pipeline Updates (Q1’25)

This review of significant changes, additions, and removals to the Bullseye Chart is exclusively for Pα+ subscribers.

If you’re not yet a subscriber, you can still view the Bullseye Chart and our Psychedelic Drug Development Tracker.

To continue reading, please log in or join Pα+…

Join Pα+ Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.


Already a member? Log In


   Regular Bulletins covering key topics and trends in the psychedelics space
   Regular articles and deep dives across psychedelic research, policy and business
   Interviews with insiders
   Monthly interactive database and commentary on psychedelic patents
   Quick-take analysis of major developments
   A Library of primers and explainers
   Access to our full back catalogue


Learn more about Pα+